SIRT6 : A potential therapeutic target for diabetic cardiomyopathy
The FASEB Journal · 2023
DOI: 10.1096/fj.202301012r ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FASEB Journal, 2023. Verfasst von Tao Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Sirtuins, Diabetes Mellitus. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The abnormal lipid metabolism in diabetic cardiomyopathy can cause myocardial mitochondrial dysfunction, lipotoxicity, abnormal death of myocardial cells, and myocardial remodeling. Mitochondrial homeostasis and normal lipid metabolism can effectively slow down the development of diabetic cardiomyopathy. Recent studies have shown that SIRT6 may play an important role in the pathological changes of diabetic cardiomyopathy such as myocardial cell death, myocardial hypertrophy, and myocardial fibrosis by regulating mitochondrial oxidative stress and glucose and lipid metabolism. Therefore, understanding the function of SIRT6 and its role in the pathogenesis of diabetic cardiomyopathy is of great significance for exploring and developing new targets and drugs for the treatment of diabetic cardiomyopathy. This article reviews the latest findings of SIRT6 in the pathogenesis of diabetic cardiomyopathy, focusing on the regulation of mitochondria and lipid metabolism by SIRT6 to explore potential clinical treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Department of Cardiology, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, China.
ORCID-Profile: Tao Wu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, T., Qu, Y., Xu, S., Wang, Y., Liu, X., & Ma, D. (2023). SIRT6 : A potential therapeutic target for diabetic cardiomyopathy. The FASEB Journal. https://doi.org/10.1096/fj.202301012r
Vancouver
Wu T, Qu Y, Xu S, Wang Y, Liu X, Ma D. SIRT6 : A potential therapeutic target for diabetic cardiomyopathy. The FASEB Journal. 2023. doi:10.1096/fj.202301012r
BibTeX
@article{Wu2023,
author = {Wu, Tao and Qu, Yiwei and Xu, Shengjie and Wang, Yong and Liu, Xue and Ma, Dufang},
title = {SIRT6 : A potential therapeutic target for diabetic cardiomyopathy},
journal = {The FASEB Journal},
year = {2023},
doi = {10.1096/fj.202301012r}
}
EUVIMED